Catalent, Inc. to Present at the SVB Leerink 10th Annual Global Healthcare Conference

Rhea-AI Summary

Catalent, Inc. (NYSE: CTLT), a global leader in drug delivery and manufacturing, announced its executive leadership will present virtually at the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021, at 11:20 a.m. ET. A live webcast of the presentation will be available at investor.catalent.com and can be replayed afterward.

Catalent has over 85 years of experience, employs over 14,000 staff, and generated over $3 billion in revenue in fiscal year 2020.

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that members of its executive leadership team will virtually present at the SVB Leerink 10^th Annual Global Healthcare Conference at 11:20 a.m. ET on February 25, 2021.

A live webcast of the presentation will be accessible at http://investor.catalent.com and will be available for replay following the event.

About Catalent, Inc.

Catalent, Inc. (NYSE: CTLT), an S&P 500^® Company, is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 14,000 people, including over 2,400 scientists and technicians, at more than 40 facilities across four continents, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com.

More products. Better treatments. Reliably supplied.™

View source version on businesswire.com: https://www.businesswire.com/news/home/20210219005442/en/

FAQ

When is Catalent's presentation at the SVB Leerink Conference?

Catalent's presentation is scheduled for February 25, 2021, at 11:20 a.m. ET.

Where can I watch the Catalent presentation?

The presentation can be viewed live at investor.catalent.com.

What does Catalent, Inc. specialize in?

Catalent specializes in advanced delivery technologies and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products.

How many employees does Catalent have?

Catalent employs over 14,000 people, including more than 2,400 scientists and technicians.

What was Catalent's revenue in fiscal year 2020?

Catalent generated over $3 billion in annual revenue in fiscal year 2020.